Filters byReset all
Conference Search Results
Search Criteria : Surgical Oncology ×
Oct 01, 2012 - May 20, 2021 | CME : 1 | USD $75.00
Screening Breast Ultrasound is organized by Institute For Advanced Medical Education (IAME). Date of Release: October 1, 2012 Date of Most Recent Review: May 20, 2018 Expiration Date: May 20, 2021 Accreditation: The Institute for Advanced Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Educational Objectives : After completing this course, the participant should be able: • to describe when and why screening breast ultrasound should be used • to describe the scanning technique of screening breast ultrasound • to discuss the ultrasound findings of cystic and solid breast masses
Dec 01, 2016 - Nov 30, 2021 | CME : 0.5
Miami Cancer Institute Overview and Evolution of Surgical Therapy for Breast Cancer is organized by Baptist Health South Florida. Dates: Course opens: 12/01/2016 Course expires: 11/30/2021 Accreditation: Baptist Health South Florida designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Available Credits: • 0.50 AMA PRA Category 1 Credit™ • 0.50 General certificate of attendance Description: Miami Cancer Institute Founding CEO Michael Zinner, M.D., FACS, provides an introduction to the Institute, discusses available services and gives an overview of the state-of-the-art cancer care now available in South Florida. Objectives: • Explain the advanced cancer diagnostic and treatment technology available through Miami Cancer Institute (MCI), and recognize the increased opportunities for patient access to local research trials available from MCI’s partnership with Memorial Sloan Kettering. • Explain the range of surgical interventions used to stage and treat breast cancer to better discuss possible treatment interventions with newly diagnosed patients. Additional details will be posted as soon as they are available.
Oct 23 - 24, 2020 | CME : 10 | Contact Hours : 10 | CEUs : 1 | Asheville, North Carolina
"Virtual" 32nd Annual Fall Foliage Cancer Conference will be held from Oct 23 - 24, 2020 starting with introductions at 12:50pm and the first talk at 1PM on Friday and conclude at 5pm. Saturday will start at 8:50am and conclude at 4pm. The conferece will have 10 45-minute presentations that are pre-recorded with 15minutes of live Q&A. The presentations will be available post activity for two weeks in case you miss a presentation. Accreditation: Atrium Health designates this activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in this activity. The Charlotte Area Health Education Center (AHEC) designates this continuing education program as fulfilling the requirement for a maximum of 1.0 Continuing Education Units (CEUs), representing 10.0 Contact Hours. Description: Topics this year include "Updates on Genitourinary and Gastrointestinal Cancers". Presentations on Prostate, Renal Cell, Bladder, Pancreatic and other GI Cancers. During this two day conferece, a faculty of distinguished physicians will share their knowledge on the most current therapies for these cancers. Confirmed speakers include: Jason Efstathiou, MD, DPhil and Christopher Willett, MD. More details to follow. Registration coming soon. This two day conference is designed to give the practicing physician and allied health providers a review of the current treatment management for genitourinary and gastrointestinal cancers. Physicians, distinguished as teachers and oncologists, will share their knowledge and experience. The conference is co-sponsored by Community Cancer Education Inc. (21st Century CARE) and Charlotte AHEC. Objectives: • Describe emerging developments in bladder cancer treatments • Discuss the updates in radiation treatments for bladder cancer • Define current surgical care in the treatment of prostate cancer • Describe the updates in radiation therapy for prostate cancer • Discuss updates in genetics for gastrointestinal cancers • Discuss updates in immunotherapies and targeted therapies for gastrointestinal cancers • Define the use of precision medicine in treating gastrointestinal cancers • Evaluate the radiation oncology treatment plans for gastrointestinal cancers • Discuss the therapeutic advancements in pancreatic cancer • Describe the updates in surgical options for treating pancreatic cancer
9th Annual New Therapeutics in Oncology: The Road to Personalized Medicine Featuring The Fenmore Lectureship and The Redlich Lectureship
Nov 13, 2020 | CME : 9 | Hours : 9
9th Annual New Therapeutics in Oncology: The Road to Personalized Medicine Featuring The Fenmore Lectureship and The Redlich Lectureship is organized by Cedars-Sinai Medical Center and will be held on Nov 13, 2020. Modules Release/Expiration Dates: Release Date: November 1, 2020 Expiration Date: October 31, 2021 Live Virtual Activity: November 13, 2020 Accreditation: Credit Designation Statement: Cedars-Sinai Medical Center designates this blended on-demand and live virtual activity for a maximum of 9.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credits: AMA PRA Category 1 Credit(s)™ (MD, DO) (9.00 hours), Non-Physician Attendance (RN, NP, PA and Others) (9.00 hours) Overview: This important educational activity will include a Live Virtual Activity on November 13, 2020 and a series of 15 on-demand modules. The activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The content will cover drug and treatment updates with a focus on myeloma, gynecological malignancies, hematologic malignancies, sarcoma, bladder cancer and GI malignancies. The activity features a comprehensive review of new drugs approved in 2020 along with their mechanism of action, next generation CAR cell therapies and a keynote lecture outlining advances in immunotherapy. Next generation studies will also be addressed, and the activity will offer participants a module designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy. Objectives: • Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trials data and apply relevant findings into the management of cancer patients • Develop personalized treatment plans for patients based upon an evaluation of efficacy and safety of current and newly approved agents and therapeutic options • Integrate appropriate strategies into clinical practice to optimize the management of patients with gynecologic malignancies to improve patient outcomes • Utilize AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning • Anticipate the needs and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team
MSK in collaboration with University of Hawaii present APPLE's Single Topic Conference: Hepatocellular Carcinoma Tumor Immune Micro Environment
Dec 04 - 05, 2020
MSK in collaboration with University of Hawaii present APPLE's Single Topic Conference (STC): Hepatocellular Carcinoma Tumor Immune Micro Environment is organized by Memorial Sloan Kettering Cancer Center (MSKCC). This Online CME Course will be held as a fully web-based course on Dec 04 - 05, 2020. Accreditation: Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Course Overview: This MSK virtual conference is hosted in collaboration with the University of Hawaii and endorsed by the Asian Pacific Primary Liver Cancer Expert Association (APPLE). This is a single topic conference focused on the Hepatocellular Carcinoma Tumor Immune Microenvironment and the use of checkpoint inhibitors in combination with other therapies including anti-angiogenics, tyrosine kinase inhibitors, other checkpoint inhibitors, and other local therapies. This conference is intended for medical oncologists, hepatologists, gastroenterologists, interventional radiologists, surgeons, radiation oncologists, immunologists, and basic science experts. MSK and the University of Hawaii are excited to host this conference virtually and welcome APPLE to the other side of the Pacific! Course Objectives: • Identify the elements of the tumor immune microenvironment • Learn the outcome data of the different checkpoint inhibitors combination therapies for hepatocellular carcinoma • Assess potential role of tumor immune microenvironment in response to therapy
Feb 26 - 27, 2021 | CME : 11
Gastroenterology | Surgical Oncology | Radiation Oncology | Pediatric Gastroenterology Hepatology and Nutrition
THORACon: Current Medical and Surgical Management of Esophageal Disease Conference is organized by Baylor College of Medicine (BCM) and will be held from Feb 26 - 27, 2021. Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Texas Heart Institute and Baylor College of Medicine. Texas Heart Institute is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Texas Heart Institute designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Description: Registration is now open for the Current Medical and Surgical Management of Esophageal Disease conference, which will host distinguished speakers from across the nation, and feature state-of-the-art lectures and videos of procedures from experts in esophageal disorders, including achalasia, gastroesophageal reflux disease, Barrett's esophagus, and esophageal cancer. The conference encourages multidisciplinary collaboration between gastroenterologists, surgeons, and other health care providers who care for patients with esophageal disorders and features information that will be useful for advancing every day clinical practice.
| USD $75.00
SSO 2020 - International Conference on Surgical Cancer Care is organized by the Society of Surgical Oncology (SSO). SSO 2020 Cancelled and Converted to Virtual Meeting Format In the idea of the many challenges presented by COVID-19 along with SSO’s mission of ensuring the health and safety of SSO 2020 attendees, the SSO Executive Council has made the challenging decision to forgo the live meeting planned for August and instead convert SSO 2020 to a virtual format. Please plan to accompany your colleagues for a live, virtual event in August. The SSO 2020 Scientific Program Committee (SPC) is planning a virtual meeting with an abbreviated program schedule that will include general sessions, featured lecturers, and several disease-site sessions. Select sessions will be documented and available on-demand. The SPC is hard at work reforming the session and additional details along are forthcoming. Additional details will be posted as soon as information is available.
Sep 15, 2010 - Oct 31, 2022 | Credits : 1
JDMS: Scanning the Post-Thyroidectomy Neck: Appearance and Technique is organized by Society of Diagnostic Medical Sonography (SDMS). Start Date: 09/15/2010 Expiration Date: 10/31/2022 Accreditation: This Course has been approved for a maximum of 1.0 Credits Description: Thyroid cancer is the most common type of endocrine cancer. In 2009, there were approximately 37,200 cases newly diagnosed. Sonography is becoming the modality of choice to evaluate the neck preoperatively and postoperatively. Accurate scanning and evaluation is essential for proper diagnosis, surgical approach, and staging. Additional details will be posted as soon as information is available.
Oct 20, 2017 - Jun 01, 2022 | CME : 10.5 | Free
Surgical Oncology - Medical Informatics (CERNER) is organized by Baptist Health South Florida. Course opens: 10/20/2017 Course expires: 06/01/2022 Accreditation: Baptist Health South Florida designates this enduring material for a maximum of 4.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Available Credit: 10.50 AMA PRA Category 1 Credit™ 10.50 Nurse Practitioners 10.50 General certificate of attendance Course Description: Learning Objectives: • Navigate and utilize Cerner electronic medical record system. • Reduce redundancy and improve delivery of care throughout Baptist Health South Florida entities utilizing a single centralized system for clinicians to review patients’ progress against expected outcomes, document findings, initiate and update orders and receive important timely notifications which affect patient treatment plans. Additional details will be posted as soon as information is available.
Sep 12, 2018 - Sep 12, 2021 | CME : 1 | Credit : 1 | USD $0.00
Shared Decision Making: Essential Skills for Prostate, Lung & Breast Cancer Screening is organized by Massachusetts Medical Society (MMS) Activity Term: Original Release Date: September 12, 2018 Termination Date: September 12, 2021 Accreditation: AMA Credit Designation Statement The Massachusetts Medical Society designates this internet enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. National Commission on Certification of Physicians Assistant (NCCPA) Physician Assistants may claim a maximum of 1.000 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Course Description: For patients, making decisions about getting screening tests for cancer involves weighing the benefits of early cancer detection and the possible harms. The benefit is reduced risk of death from the cancer. Harms include over-diagnosis with associated over-treatment, the adverse effects of unnecessary diagnostic procedures, and the emotional costs of dealing with false positive test results. To assist women aged 40-49 in making decisions about breast cancer screening and supporting all patients making decisions about lung or prostate cancer screening, the best practice involves engaging patients in a robust shared decision-making (SDM) process. This process should be facilitated by a health care provider with full knowledge of the benefits and harms of a screening process and the skill to help the patient identify and apply their relevant values to the decision. This four-module webinar series is designed to equip providers with the requisite knowledge and skills for facilitating SDM for 3 cancer screening processes: prostate, lung, and breast (for women aged 40-49). Participants will learn how to interpret and communicate quantitative information about the likelihood of benefits and harms from cancer screening tests. The webinar series also highlights specific techniques for supporting patients in identifying and applying their preferences, values and beliefs related to cancer screening and the screening decision. A panel presentation that concludes the webinar offers participants practical strategies and tools for introducing SDM into clinical workflows. Course Objective: • Define and describe the key elements and 6 steps of Shared Decision Making for cancer screenings • Identify the reasons for using Shared Decision Making when offering patients cancer screening • Present and compare the benefits and risks of prostate, breast and lung cancer screening using decision aids when appropriate • Facilitate Shared Decision Making for cancer screening into practice • Identify ways and means for integrating Shared Decision Making for cancer screening into the clinical work flow of practice